These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1210 related articles for article (PubMed ID: 18349115)

  • 1. A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels.
    Stefanovic-Racic M; Perdomo G; Mantell BS; Sipula IJ; Brown NF; O'Doherty RM
    Am J Physiol Endocrinol Metab; 2008 May; 294(5):E969-77. PubMed ID: 18349115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of the hepatic malonyl-CoA-carnitine palmitoyltransferase 1A partnership creates a metabolic switch allowing oxidation of de novo fatty acids.
    Akkaoui M; Cohen I; Esnous C; Lenoir V; Sournac M; Girard J; Prip-Buus C
    Biochem J; 2009 May; 420(3):429-38. PubMed ID: 19302064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of carnitine palmitoyltransferase I in skeletal muscle in vivo increases fatty acid oxidation and reduces triacylglycerol esterification.
    Bruce CR; Brolin C; Turner N; Cleasby ME; van der Leij FR; Cooney GJ; Kraegen EW
    Am J Physiol Endocrinol Metab; 2007 Apr; 292(4):E1231-7. PubMed ID: 17179390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential regulation of carnitine palmitoyltransferase-I gene isoforms (CPT-I alpha and CPT-I beta) in the rat heart.
    Cook GA; Edwards TL; Jansen MS; Bahouth SW; Wilcox HG; Park EA
    J Mol Cell Cardiol; 2001 Feb; 33(2):317-29. PubMed ID: 11162136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The regulation of mitochondrial fatty acid oxidation and hepatic gene expression by catecholamine.
    Barke RA; Brady PS; Brady LJ
    J Surg Res; 1993 Feb; 54(2):95-101. PubMed ID: 8479178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic steatosis during convalescence from influenza B infection in ferrets with postprandial hyperinsulinemia.
    Kang ES; Galloway MS; Ellis J; Solomon SS; Bean W; Reger JF; Cook GA; Olson G
    J Lab Clin Med; 1990 Sep; 116(3):335-44. PubMed ID: 2205696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of acetyl CoA carboxylase and carnitine palmitoyl transferase-1 in rat adipocytes.
    Zang Y; Wang T; Xie W; Wang-Fischer YL; Getty L; Han J; Corkey BE; Guo W
    Obes Res; 2005 Sep; 13(9):1530-9. PubMed ID: 16222055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary phosphatidylcholine alleviates fatty liver induced by orotic acid.
    Buang Y; Wang YM; Cha JY; Nagao K; Yanagita T
    Nutrition; 2005; 21(7-8):867-73. PubMed ID: 15975496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paradoxical effects of clofibrate on liver and muscle metabolism in rats. Induction of myotonia and alteration of fatty acid and glucose oxidation.
    Paul HS; Adibi SA
    J Clin Invest; 1979 Aug; 64(2):405-12. PubMed ID: 457859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of protein restriction on the regulation of cardiac carnitine palmitoyltransferase by malonyl-CoA.
    Holness MJ; Priestman DA; Sugden MC
    J Mol Cell Cardiol; 1998 Jul; 30(7):1381-90. PubMed ID: 9710806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular therapy for obesity and diabetes based on a long-term increase in hepatic fatty-acid oxidation.
    Orellana-Gavaldà JM; Herrero L; Malandrino MI; Pañeda A; Sol Rodríguez-Peña M; Petry H; Asins G; Van Deventer S; Hegardt FG; Serra D
    Hepatology; 2011 Mar; 53(3):821-32. PubMed ID: 21319201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Ca2+ second messenger system and interleukin-1-alpha modulation of hepatic gene transcription and mitochondrial fat oxidation.
    Barke RA; Brady PS; Brady LJ
    Surgery; 1991 Aug; 110(2):285-94. PubMed ID: 1858038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of hepatic carnitine palmitoyl-transferase I (CPT IA) by valproyl-CoA as a possible mechanism of valproate-induced steatosis.
    Aires CC; Ijlst L; Stet F; Prip-Buus C; de Almeida IT; Duran M; Wanders RJ; Silva MF
    Biochem Pharmacol; 2010 Mar; 79(5):792-9. PubMed ID: 19854160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of insulin treatment on ketone body production and carnitine-palmitoyl-transferase (CPT) activity in the isolated perfused liver from streptozotocin diabetic rats.
    Tessari P; Meneghel A; Avogaro A; Nosadini R; Del Prato S; Tiengo A
    Horm Metab Res; 1985 Jun; 17(6):271-4. PubMed ID: 3160642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etomoxir-induced partial carnitine palmitoyltransferase-I (CPT-I) inhibition in vivo does not alter cardiac long-chain fatty acid uptake and oxidation rates.
    Luiken JJ; Niessen HE; Coort SL; Hoebers N; Coumans WA; Schwenk RW; Bonen A; Glatz JF
    Biochem J; 2009 Apr; 419(2):447-55. PubMed ID: 19138173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenovirus-mediated overexpression of liver carnitine palmitoyltransferase I in INS1E cells: effects on cell metabolism and insulin secretion.
    Rubí B; Antinozzi PA; Herrero L; Ishihara H; Asins G; Serra D; Wollheim CB; Maechler P; Hegardt FG
    Biochem J; 2002 May; 364(Pt 1):219-26. PubMed ID: 11988095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of hepatic but not skeletal muscle carnitine palmitoyltransferase enzyme is depressed by intravenous glucose infusions in lactating dairy cows.
    Al-Trad B; Wittek T; Gäbel G; Fürll M; Reisberg K; Aschenbach JR
    J Anim Physiol Anim Nutr (Berl); 2010 Dec; 94(6):685-95. PubMed ID: 20546068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CPT I overexpression protects L6E9 muscle cells from fatty acid-induced insulin resistance.
    Sebastián D; Herrero L; Serra D; Asins G; Hegardt FG
    Am J Physiol Endocrinol Metab; 2007 Mar; 292(3):E677-86. PubMed ID: 17062841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia.
    Julius U
    Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):246-50. PubMed ID: 12951628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 61.